Evidence map›Paper›PMID 39430389›Full record

ReviewNeuro-oncology advances2024

Current state of spinal nerve sheath tumor management and future advances.

Chloe Gui, Luxshikka Canthiya, Gelareh Zadeh, Suganth Suppiah

Abstract readReview
In one paragraph

Review in Neuro-oncology advances, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Misdiagnosed tuberculous myelitis turned out to be spinal malignant peripheral nerve sheath tumor: a case report.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Chloe GuiMacFeeters-Hamilton Centre for Neuro Oncology, Princess Margaret Cancer Research Center, Toronto, Ontario, Canada.
Luxshikka CanthiyaMacFeeters-Hamilton Centre for Neuro Oncology, Princess Margaret Cancer Research Center, Toronto, Ontario, Canada.
Gelareh ZadehMacFeeters-Hamilton Centre for Neuro Oncology, Princess Margaret Cancer Research Center, Toronto, Ontario, Canada.ORCID https://orcid.org/0000-0002-6637-4502
Suganth SuppiahMacFeeters-Hamilton Centre for Neuro Oncology, Princess Margaret Cancer Research Center, Toronto, Ontario, Canada.ORCID https://orcid.org/0000-0003-4569-0466

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nerve sheath tumors are the most common tumors of the spine after meningiomas. They include schwannomas, neurofibroma, and malignant peripheral nerve sheath tumors. These can arise sporadically or in association with tumor predisposition syndromes, including neurofibromatosis type 1, neurofibromatosis type 2, and schwannomatosis. Though surgery is the traditional mainstay of treatment for these tumors, the discovery of the genetic and molecular basis of these diseases in recent decades has prompted investigation into targeted therapies. Here, we give a clinical overview of spinal nerve sheath tumors, their imaging features, current management practices, and explore ongoing advances in systemic therapies.

Indexed as

malignant peripheral nerve sheath tumorneurofibromaneurofibromatosisschwannomaspinal nerve sheath tumor

Identifiers

PMID39430389
PMCPMC11485951

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.